We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Agglutination Latex Test Developed for Diarrheagenic Pathogens

By LabMedica International staff writers
Posted on 08 Oct 2014
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) are human intestinal pathogens responsible for diarrhea in both developing and industrialized countries.

A rapid and simple assay for EPEC/EHEC detection has been developed using the EPEC/EHEC-secreted proteins EspA and EspB, which were chosen as target antigens since they are the major secreted proteins in both pathogens.

Bacteriologists at the Instituto Butantan (São Paulo, Brazil) analyzed 71 atypical EPEC (aEPEC), 31 typical EPEC (tEPEC), and 23 EHEC belonging to different serotypes characterized as locus of enterocyte effacement (LEE)-positive isolates. More...
The secreted proteins EspA and EspB were detected using an enzyme linked immunosorbent assay and the absorbance was measured at 492 nm in a Multiskan EX ELISA reader (Thermo Scientific; Waltham, MA, USA).

For rapid agglutination latex test (RALT), bacterial isolates were grown on Dulbecco’s modified Eagle’s medium (DMEM)-agar and the tests were done using latex sensitized with anti-EspB monoclonal antibody (MAb). The RALT was performed on a slide glass using 20 µL of bacterial lysate and 20 µL of latex beads coupled to anti-EspB (MAb), and checking for agglutination after five minutes of gentle mixing. The EspB secreted protein was defined as a biomarker and its corresponding monoclonal antibody as the tool for EPEC/EHEC diagnosis; the production of EspB was better in DMEM medium.

The indirect ELISA using anti-EspB MAb showed 90.4% sensitivity and 96.4%, specificity, indicating its possible use in routine diagnostic laboratories. However, this methodology requires specific laboratory instrumentation, making it difficult to be performed in low-income country settings. The RALT assay can be considered an alternative assay for diarrhea diagnosis in low-income countries since it achieved 97% sensitivity, 98% specificity and 97% efficiency. RALT assay has the sensitivity and specificity required for high-impact diagnosis of neglected diseases in the developing world.

The authors concluded that serotyping-based diagnosis is the only methodology available in limited-resources settings, employing either commercial or in-house antisera. The standardized RALT for detection of EPEC and EHEC will have a remarkable impact in the diagnosis of these pathotypes, as the established agglutination latex test is a simple, rapid and easy to perform test, which can be employed in less equipped laboratories in low-income countries. The study was published on September 25, 2014, in the Public Library of Science Neglected Tropical Diseases.

Related Links:

Instituto Butantan 
Thermo Scientific



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Student researcher Liyan Ming, first author of the study, setting up a fluorescence imaging experiment (Photo courtesy of Riccardo Marin)

Safer, Portable and Low-Cost Imaging Solution to Revolutionize Biomedical Diagnostics

In diagnosing diseases and monitoring treatment, accurate and quick detection of temperature within biological tissues can be crucial, especially in early disease detection. Conventional methods such as... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.